R. Bone, Sepsis and Coagulation, Chest, vol.101, issue.3, pp.594-596, 1992.
DOI : 10.1378/chest.101.3.594

W. Aird, Sepsis and Coagulation, Critical Care Clinics, vol.21, issue.3, pp.417-431, 2005.
DOI : 10.1016/j.ccc.2005.04.004

J. Diehl and D. Borgel, Sepsis and coagulation, Current Opinion in Internal Medicine, vol.4, issue.6, pp.454-460, 2005.
DOI : 10.1097/01.ccx.0000176692.03186.e7

M. Levi, E. De-jonge, and T. Van-der-poll, Sepsis and Disseminated Intravascular Coagulation, Journal of Thrombosis and Thrombolysis, vol.16, issue.1/2, pp.43-47, 2003.
DOI : 10.1023/B:THRO.0000014592.27892.11

M. Levi, Disseminated intravascular coagulation, Critical Care Medicine, vol.35, issue.9, pp.2191-2195, 2007.
DOI : 10.1097/01.CCM.0000281468.94108.4B

M. Levi, T. Cate, and H. , Disseminated Intravascular Coagulation, New England Journal of Medicine, vol.341, issue.8, pp.586-592, 1999.
DOI : 10.1056/NEJM199908193410807

D. Borgel, C. Bornstain, P. Reitsma, N. Lerolle, S. Gandrille et al., A Comparative Study of the Protein C Pathway in Septic and Nonseptic Patients with Organ Failure, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.9, pp.878-885, 2007.
DOI : 10.1164/rccm.200611-1692OC

F. Fourrier, C. Chopin, J. Goudemand, S. Hendrycx, C. Caron et al., Septic Shock, Multiple Organ Failure, and Disseminated Intravascular Coagulation, Chest, vol.101, issue.3, pp.816-823, 1992.
DOI : 10.1378/chest.101.3.816

S. Gando, T. Kameue, Y. Morimoto, N. Matsuda, M. Hayakawa et al., Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis*, Critical Care Medicine, vol.30, issue.8, pp.1729-1734, 2002.
DOI : 10.1097/00003246-200208000-00009

E. Abraham, K. Reinhart, S. Opal, I. Demeyer, C. Doig et al., Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis, JAMA, vol.290, issue.2, pp.238-247, 2003.
DOI : 10.1001/jama.290.2.238

B. Warren, A. Eid, P. Singer, S. Pillay, P. Carl et al., High-Dose Antithrombin III in Severe Sepsis, JAMA, vol.286, issue.15, pp.1869-1878, 2001.
DOI : 10.1001/jama.286.15.1869

S. Kayal, J. Jais, N. Aguini, and J. Labrousse, Elevated Circulating E-Selectin, Intercellular Adhesion Molecule 1, and von Willebrand Factor in Patients with Severe Infection, American Journal of Respiratory and Critical Care Medicine, vol.157, issue.3, pp.776-784, 1998.
DOI : 10.1164/ajrccm.157.3.9705034

L. Ware, M. Eisner, B. Thompson, P. Parsons, and M. Matthay, Significance of Von Willebrand Factor in Septic and Nonseptic Patients with Acute Lung Injury, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.7, pp.766-772, 2004.
DOI : 10.1164/rccm.200310-1434OC

M. Furlan, R. Robles, M. Galbusera, G. Remuzzi, P. Kyrle et al., von Willebrand Factor???Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic???Uremic Syndrome, New England Journal of Medicine, vol.339, issue.22, pp.1578-1584, 1998.
DOI : 10.1056/NEJM199811263392202

H. Tsai and E. Lian, Antibodies to von Willebrand Factor???Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura, New England Journal of Medicine, vol.339, issue.22, pp.1585-1594, 1998.
DOI : 10.1056/NEJM199811263392203

. Asaday, . Sumiyoshia, . Hayashit, and K. Suzumiyaj, Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen, Thrombosis Research, vol.38, issue.5, pp.469-479, 1985.
DOI : 10.1016/0049-3848(85)90180-X

J. Moake, Thrombotic Microangiopathies, New England Journal of Medicine, vol.347, issue.8, pp.589-600, 2002.
DOI : 10.1056/NEJMra020528

P. Coppo, D. Bengoufa, A. Veyradier, M. Wolf, A. Bussel et al., Severe ADAMTS13 Deficiency in Adult Idiopathic Thrombotic Microangiopathies Defines a Subset of Patients Characterized by Various Autoimmune Manifestations, Lower Platelet Count, and Mild Renal Involvement, Medicine, vol.83, issue.4, pp.233-244, 2004.
DOI : 10.1097/01.md.0000133622.03370.07

P. Coppo, C. Adrie, E. Azoulay, G. Leleu, E. Oksenhendler et al., Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (icu) patients? Intensive Care Med, pp.564-569, 2003.

T. Ono, J. Mimuro, S. Madoiwa, K. Soejima, Y. Kashiwakura et al., Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure, Blood, vol.107, issue.2, pp.528-534, 2006.
DOI : 10.1182/blood-2005-03-1087

K. Martin, D. Borgel, N. Lerolle, H. Feys, L. Trinquart et al., Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure*, Critical Care Medicine, vol.35, issue.10, pp.2375-2382, 2007.
DOI : 10.1097/01.CCM.0000284508.05247.B3

B. Levy, P. Lacolley, and V. Regnault, ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin) and endothelial dysfunction in sepsis: Marker or culprit?*, Critical Care Medicine, vol.35, issue.10, pp.2453-2454, 2007.
DOI : 10.1097/01.CCM.0000284735.46290.05

J. Hovinga, S. Zeerleder, P. Kessler, R. De-wit, T. Van-mourik et al., ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock, Journal of Thrombosis and Haemostasis, vol.86, issue.11, pp.2284-2290, 2007.
DOI : 10.1073/pnas.84.7.1955

C. Bockmeyer, R. Claus, U. Budde, K. Kentouche, R. Schneppenheim et al., Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor, Haematologica, vol.93, issue.1, pp.137-140, 2008.
DOI : 10.3324/haematol.11677

R. Claus, C. Bockmeyer, U. Budde, K. Kentouche, M. Sossdorf et al., Variations in the ratio between von Willebrand factor and its cleaving protease during systemic inflammation and association with severity and prognosis of organ failure, Thrombosis and Haemostasis, vol.101, pp.239-247, 2009.
DOI : 10.1160/TH08-03-0161

J. Hyun, H. Kim, J. Kim, M. Lim, J. Jung et al., Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation, Thrombosis Research, vol.124, issue.1, pp.75-79, 2009.
DOI : 10.1016/j.thromres.2008.11.020

T. Nguyen, A. Liu, L. Liu, C. Ball, H. Choi et al., Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis, Haematologica, vol.92, issue.1, pp.121-124, 2007.
DOI : 10.3324/haematol.10262

T. Nguyen, Y. Han, J. Kiss, M. Hall, A. Hassett et al., Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure*, Critical Care Medicine, vol.36, issue.10, pp.2878-2887, 2008.
DOI : 10.1097/CCM.0b013e318186aa49

S. Pelras, Y. Delmas, D. Lamireau, F. Villega, P. Nolent et al., Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome, Pediatric Nephrology, vol.14, issue.4, pp.631-635, 2011.
DOI : 10.1007/s00467-010-1721-9

R. Bone, R. Balk, F. Cerra, R. Dellinger, A. Fein et al., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, The ACCP/SCCM consensus conference committee, pp.1644-1655, 1992.
DOI : 10.1378/chest.101.6.1644

L. Gall, J. Lemeshow, S. Saulnier, and F. , A New Simplified Acute Physiology Score (SAPS II) Based on a European/North American Multicenter Study, JAMA: The Journal of the American Medical Association, vol.270, issue.24, pp.2957-2963, 1993.
DOI : 10.1001/jama.1993.03510240069035

L. Gall, J. Klar, J. Lemeshow, S. Saulnier, F. Alberti et al., The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group, JAMA: The Journal of the American Medical Association, vol.276, issue.10, pp.802-810, 1996.
DOI : 10.1001/jama.276.10.802

F. Taylor, . Jr, C. Toh, W. Hoots, H. Wada et al., Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation, Thromb Haemost, vol.86, pp.1327-1330, 2001.

K. Bakhtiari, J. Meijers, E. De-jonge, and M. Levi, Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation*, Critical Care Medicine, vol.32, issue.12, pp.2416-2421, 2004.
DOI : 10.1097/01.CCM.0000147769.07699.E3

M. Angstwurm, C. Dempfle, and M. Spannagl, New disseminated intravascular coagulation score: A useful tool to predict mortality in comparison with Acute Physiology and Chronic Health Evaluation II and Logistic Organ Dysfunction scores, Critical Care Medicine, vol.34, issue.2, pp.314-320, 2006.
DOI : 10.1097/01.CCM.0000196832.27501.B2

A. Veyradier, E. Fressinaud, M. Sigaud, M. Wolf, and D. Meyer, A new automated method for von Willebrand factor antigen measurement using latex particles, Thromb Haemost, vol.81, pp.320-321, 1999.

E. Groot, R. Fijnheer, S. Sebastian, P. De-groot, and P. Lenting, The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission, Journal of Thrombosis and Haemostasis, vol.57, issue.Suppl. 1, pp.962-969, 2009.
DOI : 10.1111/j.1538-7836.2009.03433.x

A. Veyradier, B. Obert, A. Houllier, D. Meyer, and J. Girma, Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases, Blood, vol.98, issue.6, pp.1765-1772, 2001.
DOI : 10.1182/blood.V98.6.1765

K. Kokame, Y. Nobe, Y. Kokubo, A. Okayama, and T. Miyata, FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay, British Journal of Haematology, vol.83, issue.1, pp.93-100, 2005.
DOI : 10.1182/blood-2003-11-4035

S. Ferrari, F. Scheiflinger, M. Rieger, G. Mudde, M. Wolf et al., Prognostic value of anti-ADAMTS 13 antibody features (ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable adamts 13 activity, Blood, vol.109, pp.2815-2822, 2007.

T. Nguyen, B. Stegmayr, R. Busund, T. Bunchman, and J. Carcillo, Plasma therapies in thrombotic syndromes, Int J Artif Organs, vol.28, pp.459-465, 2005.

S. Gando, Microvascular thrombosis and multiple organ dysfunction syndrome, Critical Care Medicine, vol.38, pp.35-42, 2010.
DOI : 10.1097/CCM.0b013e3181c9e31d

Z. Wang, Z. Yu, J. Su, L. Cao, X. Zhao et al., Sepsis-Induced Disseminated Intravascular Coagulation With Features of Thrombotic Thrombocytopenic Purpura: A Fatal Fulminant Syndrome, Clinical and Applied Thrombosis/Hemostasis, vol.17, issue.3, pp.251-253, 2011.
DOI : 10.1177/1076029609357739

J. Mimuro, M. Niimura, Y. Kashiwakura, A. Ishiwata, T. Ono et al., Unbalanced expression of ADAMTS13 and von Willebrand factor in mouse endotoxinemia, Thrombosis Research, vol.122, issue.1, pp.91-97, 2008.
DOI : 10.1016/j.thromres.2007.09.011

W. Cao, M. Niiya, X. Zheng, D. Shang, and X. Zheng, Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells, Journal of Thrombosis and Haemostasis, vol.6, issue.7, pp.1233-1235, 2008.
DOI : 10.1056/NEJM199811263392203

M. Chung, T. Popova, S. Jorgensen, L. Dong, V. Chandhoke et al., Degradation of Circulating von Willebrand Factor and Its Regulator ADAMTS13 Implicates Secreted Bacillus anthracis Metalloproteases in Anthrax Consumptive Coagulopathy, Journal of Biological Chemistry, vol.283, issue.15, pp.9531-9542, 2008.
DOI : 10.1074/jbc.M705871200

J. Crawley, J. Lam, J. Rance, L. Mollica, O. Donnell et al., Proteolytic inactivation of ADAMTS13 by thrombin and plasmin, Blood, vol.105, issue.3, pp.1085-1093, 2005.
DOI : 10.1182/blood-2004-03-1101

H. Feys, N. Vandeputte, R. Palla, F. Peyvandi, K. Peerlinck et al., Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura, Journal of Thrombosis and Haemostasis, vol.120, issue.9, pp.2053-2062, 2010.
DOI : 10.1111/j.1538-7836.2010.03942.x

A. Bernardo, C. Ball, L. Nolasco, J. Moake, and J. Dong, Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow, Blood, vol.104, issue.1, pp.100-106, 2004.
DOI : 10.1182/blood-2004-01-0107

S. Oda, H. Hirasawa, H. Shiga, K. Nakanishi, K. Matsuda et al., Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)/sepsis, Cytokine, vol.29, issue.4, pp.169-175, 2005.
DOI : 10.1016/j.cyto.2004.10.010

L. Nolasco, N. Turner, A. Bernardo, Z. Tao, T. Cleary et al., Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers, Blood, vol.106, issue.13, pp.4199-4209, 2005.
DOI : 10.1182/blood-2005-05-2111

N. Lerolle, C. Dunois-lardé, I. Badirou, D. Motto, G. Hill et al., von Willebrand factor is a major determinant of ADAMTS-13 decrease during mouse sepsis induced by cecum ligation and puncture, Journal of Thrombosis and Haemostasis, vol.17, issue.5, pp.843-850, 2009.
DOI : 10.1111/j.1538-7836.2009.03313.x

C. Bockmeyer, P. Reuken, T. Simon, U. Budde, W. Lösche et al., ADAMTS13 activity is decreased in a septic porcine model, Thrombosis and Haemostasis, vol.105, issue.1, pp.145-153, 2011.
DOI : 10.1160/TH10-03-0153

R. Reiter, K. Varadi, P. Turecek, B. Jilma, and P. Knöbl, Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation, Thrombosis and Haemostasis, vol.93, pp.554-558, 2005.
DOI : 10.1160/TH04-08-0467

D. Motto, A. Chauhan, G. Zhu, J. Homeister, C. Lamb et al., Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice, Journal of Clinical Investigation, vol.115, issue.10, pp.2752-2761, 2005.
DOI : 10.1172/JCI26007DS1

A. Chauhan, M. Walsh, G. Zhu, D. Ginsburg, D. Wagner et al., The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis, Blood, vol.111, issue.7, pp.3452-3457, 2008.
DOI : 10.1182/blood-2007-08-108571

A. Chauhan, J. Kisucka, A. Brill, M. Walsh, F. Scheiflinger et al., ADAMTS13: a new link between thrombosis and inflammation, The Journal of Experimental Medicine, vol.150, issue.9, pp.2065-2074, 2008.
DOI : 10.1016/0026-2862(78)90009-2

J. Huang, D. Motto, D. Bundle, and J. Sadler, Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice, Blood, vol.116, issue.18, pp.3653-3659, 2010.
DOI : 10.1182/blood-2010-02-271957

S. Finfer, V. Ranieri, B. Thompson, P. Barie, J. Dhainaut et al., Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock, Intensive Care Medicine, vol.32, issue.Suppl 2, pp.1935-1947, 2008.
DOI : 10.1007/s00134-008-1266-6

. Peigne, The prognostic value of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13) deficiency in septic shock patients involves interleukin-6 and is not dependent on disseminated intravascular coagulation, Critical Care, vol.17, issue.6, pp.10-1186, 2013.
DOI : 10.1007/s00134-008-1266-6
URL : https://hal.archives-ouvertes.fr/inserm-00926824